ArticleScience advances2020

Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells.

Seung Ho Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.